Signaling through CD70 regulates B cell activation and IgG production

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 3901-3908

  Arens, Ramon ^a   Nolte, Martijn A ^a   Tesselaar, Kiki ^a,b   Heemskerk, Bianca ^a,c   Reedquist, Kris A ^a   Van Lier, René A W ^a   Van Oers, Marinus H J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CD70 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; FAS ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 4644324552     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.3901     Document Type: Article

References (43)

1. Bishop, G. A., and B. S. Hostager. 2001. B lymphocyte activation by contact-mediated interactions with T lymphocytes. Curr. Opin. Immunol. 13:278.
2. Chan, K. F., M. R. Siegel, and J. M. Lenardo. 2000. Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity 13:419.
3. Eissner, G., S. Kirchner, H. Lindner, W. Kolch, P. Janosch, M. Grell, P. Scheurich, R. Andreesen, and E. Holler. 2000. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J. Immunol. 164:6193.
4. Wiley, S. R., R. G. Goodwin, and C. A. Smith. 1996. Reverse signaling via CD30 ligand. J. Immunol. 157:3635.
5. + T lymphocytes. J. Immunol. 152:1523.
6. Van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced costimulation of T cells in the development of helper function. Nature 378:620.
7. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123.
8. Langstein, J., J. Michel, J. Fritsche, M. Kreutz, R. Andreesen, and H. Schwarz. 1998. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J. Immunol. 160:2488.
9. Stuber, E., M. Neurath, D. Calderhead, H. P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2:507.
10. Chen, N. J., M. W. Huang, and S. L. Hsieh. 2001. Enhanced secretion of IFN-γ by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J. Immunol. 166:270.
11. Chou, A. H., H. F. Tsai, L. L. Lin, S. L. Hsieh, P. I. Hsu, and P. N. Hsu. 2001. Enhanced proliferation and increased IFN-γ production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J. Immunol. 167:1347.
12. Wan, X., J. Zhang, H. Luo, G. Shi, E. Kapnik, S. Kim, P. Kanakaraj, and J. Wu. 2002. A TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 169:6813.
13. Van Lier, R. A., J. Borst, T. M. Vroom, H. Klein, P. Van Mourik, W. P. Zeijlemaker, and C. J. Melief. 1987. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139:1589.
14. Sugita, K., M. J. Robertson, Y. Torimoto, J. Ritz, S. F. Schlossman, and C. Morimoto. 1992. Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J. Immunol. 149:1199.
15. Wiesmann, A., R. L. Phillips, M. Mojica, L. J. Pierce, A. E. Searles, G. J. Spangrude, and I. Lemischka. 2000. Expression of CD27 on murine hematopoietic stem and progenitor cells. Immunity 12:193.
16. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679.
17. Oshima, H., H. Nakano, C. Nohara, T. Kobata, A. Nakajima, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, T. Muto, H. Yagita, and K. Okumura. 1998. Characterization of murine CD70 by molecular cloning and mAb. Int. Immunol. 10:517.
18. Tesselaar, K., Y. Xiao, R. Arens, G. M. van Schijndel, D. H. Schuurhuis, R. E. Mebius, J. Borst, and R. A. van Lier. 2003. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170:33.
19. Goodwin, R. G., M. R. Alderson, C. A. Smith, R. J. Armitage, T. VandenBos, R. Jerzy, T. W. Tough, M. A. Schoenborn, T. Davis-Smith, and K. Hennen. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73:447.
20. Hintzen, R. Q., S. M. Lens, K. Lammers, H. Kuiper, M. P. Beckmann, and R. A. van Lier. 1995. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154:2612.
21. Hendriks, J., L. A. Gravestein, K. Tesselaar, R. A. van Lier, T. N. Schumacher, and J. Borst. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433.
22. Arens, R., K. Tesselaar, P. A. Baars, G. M. van Schijndel, J. Hendriks, S. T. Pals, P. Krimpenfort, J. Borst, M. H. van Oers, and R. A. van Lier. 2001. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion. Immunity 15:801.
23. Kobata, T., S. Jacquot, S. Kozlowski, K. Agematsu, S. F. Schlossman, and C. Morimoto. 1995. CD27-CD70 interactions regulate B-cell activation by T cells. Proc. Natl. Acad. Sci. USA 92:11249.
24. Jacquot, S., T. Kobata, S. Iwata, C. Morimoto, and S. F. Schlossman. 1997. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J. Immunol. 159:2652.
25. Agematsu, K., H. Nagumo, Y. Oguchi, T. Nakazawa, K. Fukushima, K. Yasui, S. Ito, T. Kobata, C. Morimoto, and A. Komiyama. 1998. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 91:173.
26. Stein, H., H. Herbst, I. Anagnostopoulos, G. Niedobitek, F. Dallenbach, and H. C. Kratzsch. 1991. The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Ann. Oncol. 2(Suppl. 2):33.
27. Ranheim, E. A., M. J. Cantwell, and T. J. Kipps. 1995. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 85:3556.
28. Lens, S. M., P. Drillenburg, B. F. den Drijver, G. van Schijndel, S. T. Pals, R. A. van Lier, and M. H. van Oers. 1999. Aberrant expression and reverse signalling of CD70 on malignant B cells. Br. J. Haematol. 106:491.
29. Agathanggelou, A., G. Niedobitek, R. Chen, J. Nicholls, W. Yin, and L. S. Young. 1995. Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma: evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. Am. J. Pathol. 147:1152.
30. Hishima, T., M. Fukayama, Y. Hayashi, T. Fujii, T. Ooba, N. Funata, and M. Koike. 2000. CD70 expression in thymic carcinoma. Am. J. Surg. Pathol. 24:742.
31. Held-Feindt, J., and R. Mentlein. 2002. CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors. Int. J. Cancer 98:352.
32. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
33. Reif, K., E. H. Ekland, L. Ohl, H. Nakano, M. Lipp, R. Forster, and J. G. Cyster. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416:94.
34. De Jong, R., W. A. Loenen, M. Brouwer, L. van Emmerik, E. F. de Vries, J. Borst, and R. A. van Lier. 1991. Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors. J. Immunol. 146:2488.
35. Xiao, Y., J. Hendriks, P. Langerak, H. Jacobs, and J. Borst. 2004. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J. Immunol. 172:7432.
36. Lens, S. M., R. M. Keehnen, M. H. van Oers, R. A. van Lier, S. T. Pals, and G. Koopman. 1996. Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. Eur. J. Immunol. 26:1007.
37. Hodgkin, P. D., J. H. Lee, and A. B. Lyons. 1996. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184:277.
38. Watts, A. D., N. H. Hunt, Y. Wanigasekara, G. Bloomfield, D. Wallach, B. D. Roufogalis, and G. Chaudhri. 1999. A casein kinase I mofif present in the cytoplasmic domain of members of the tumor necrosis factor ligand family is implicated in 'reverse signalling.' EMBO J. 18:2119.
39. Matsumura, Y., T. Hori, S. Kawamata, A. Imura, and T. Uchiyama. 1999. Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J. Immunol. 163:3007.
40. Jacob, A., D. Cooney, M. Pradhan, and K. M. Coggeshall. 2002. Convergence of signaling pathways on the activation of ERK in B cells. J. Biol. Chem. 277:23420.
41. Zhu, Y., J. Hollmen, R. Raty, Y. Aalto, B. Nagy, E. Elonen, J. Kere, H. Mannila, K. Franssila, and S. Knuutila. 2002. Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. Br. J. Haematol. 119:905.
42. Oudejans, J. J., N. M. Jiwa, J. A. Kummer, G. J. Ossenkoppele, P. van Heerde, J. W. Baars, P. M. Kluin, J. C. Kluin-Nelemans, P. J. van Diest, J. M. Middeldorp, and C. J. Meijer. 1997. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood 89:1376.
43. Ten Berge, R. L., D. F. Dukers, J. J. Oudejans, K. Pulford, G. J. Ossenkoppele, D. de Jong, J. F. Misere, and C. J. Meijer. 1999. Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma. Blood 93:2688.